About Enzyre
Enzyre is a company based in Nijmegen (Netherlands) founded in 2016.. Enzyre has raised $11.88 million across 2 funding rounds from investors including Demcon, Oost NL and i&i Bio. Enzyre offers products and services including ENZYSYSTEM, ENZYCARD, and ENZYPAD. Enzyre operates in a competitive market with competitors including Accriva Diagnostics, Diagnostica Stago, Entegrion, MedicQuant ApS and Perosphere, among others.
- Headquarter Nijmegen, Netherlands
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Enzyre Bv
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$11.88 M (USD)
in 2 rounds
-
Latest Funding Round
$11.88 M (USD), Series A
Nov 02, 2022
-
Investors
Demcon
& 4 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Enzyre
Enzyre offers a comprehensive portfolio of products and services, including ENZYSYSTEM, ENZYCARD, and ENZYPAD. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Integrated platform for blood coagulation analysis and data sharing.
Single-use device for blood sample testing and reagent processing.
Reusable unit that handles blood analysis and transfers results to cloud.
Unlock access to complete
Unlock access to complete
Funding Insights of Enzyre
Enzyre has successfully raised a total of $11.88M across 2 strategic funding rounds. The most recent funding activity was a Series A round of $11.88 million completed in November 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 2
- Last Round Series A — $11.9M
- First Round First Round
- Investors Count 5
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Nov, 2022 | Amount | Series A - Enzyre | Valuation | Oost NL | |
| Jul, 2020 | Amount | Seed - Enzyre | Valuation | Novalis Biotech |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Enzyre
Enzyre has secured backing from 5 investors, including venture fund and institutional investors. Prominent investors backing the company include Demcon, Oost NL and i&i Bio. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Sector-agnostic VC firm investing in geographies such as the Netherlands
|
Founded Year | Domain | Location | |
|
-
|
Founded Year | Domain | Location | |
|
Early-stage venture capital investment is provided in life sciences.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Enzyre
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Enzyre
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Enzyre Comparisons
Competitors of Enzyre
Enzyre operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Accriva Diagnostics, Diagnostica Stago, Entegrion, MedicQuant ApS and Perosphere, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Near-patient diagnostic systems for coagulation testing are developed.
|
|
| domain | founded_year | HQ Location |
A portfolio of hemostasis and coagulation diagnostic products is manufactured.
|
|
| domain | founded_year | HQ Location |
Hemostasis and fluid replacement products are provided for medical applications.
|
|
| domain | founded_year | HQ Location |
Diagnostic kits for blood anticoagulant detection are provided.
|
|
| domain | founded_year | HQ Location |
Anticoagulant reversal agent and small molecules to prevent allergic reactions, traumatic brain injury.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Enzyre
Frequently Asked Questions about Enzyre
When was Enzyre founded?
Enzyre was founded in 2016 and raised its 1st funding round 4 years after it was founded.
Where is Enzyre located?
Enzyre is headquartered in Nijmegen, Netherlands. It is registered at Nijmegen, Gelderland, Netherlands.
Is Enzyre a funded company?
Enzyre is a funded company, having raised a total of $11.88M across 2 funding rounds to date.
What does Enzyre do?
Enzyre was founded in 2016 and is based in Nijmegen, Netherlands. Operations center on the medical diagnostics sector, where ENZYPAD devices are produced for blood coagulation testing. Painless blood sampling is facilitated through single-use microfluidic cartridges that incorporate necessary reagents and controls. Proprietary latent luciferin-protected peptide substrates are utilized to measure specific enzyme activities in the coagulation cascade.
Who are the top competitors of Enzyre?
Enzyre's top competitors include Accriva Diagnostics, Diagnostica Stago and MedicQuant ApS.
What products or services does Enzyre offer?
Enzyre offers ENZYSYSTEM, ENZYCARD, and ENZYPAD.
Who are Enzyre's investors?
Enzyre has 5 investors. Key investors include Demcon, Oost NL, i&i Bio, Novalis Biotech, and Takeda Ventures.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.